000			01979 a2200565 4500
005			20250514045711.0
264		0	_c20021029
008			200210s 0 0 eng d
022			_a0008-543X
024	7		_a10.1002/cncr.10842 _2doi
040			_aNLM _beng _cNLM
100	1		_aGez, Eliahu
245	0	0	_aInterleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000. _h[electronic resource]
260			_bCancer _cOct 2002
300			_a1644-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInjections, Intravenous
650	0	4	_aInjections, Subcutaneous
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aInterleukin-2 _xadministration & dosage
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNephrectomy
650	0	4	_aProspective Studies
650	0	4	_aTreatment Outcome
650	0	4	_aVinblastine _xadministration & dosage
700	1		_aRubinov, Raphael
700	1		_aGaitini, Diana
700	1		_aMeretyk, Shimon
700	1		_aBest, Lael-Anson
700	1		_aNative, Ofer
700	1		_aStein, Avi
700	1		_aErlich, Nahum
700	1		_aBeny, Alexander
700	1		_aZidan, Jamal
700	1		_aHaim, Nissim
700	1		_aKuten, Abraham
773	0		_tCancer _gvol. 95 _gno. 8 _gp. 1644-9
856	4	0	_uhttps://doi.org/10.1002/cncr.10842 _zAvailable from publisher's website
999			_c12176039 _d12176039